Eric C Hsu insider trades

Open-market stock purchases and sales by Eric C Hsu, Sr. VP, Pre-Clinical Res/Dev at InMed Pharmaceuticals Inc, from SEC Form 4 filings since Dec 16, 2020.

Recent trades

DateStockTradeValue
Dec 19, 2025INM InMed Pharmaceuticals IncBought (not open market)—
Dec 15, 2025INM InMed Pharmaceuticals IncSold (not open market)—

Companies traded

  • INM InMed Pharmaceuticals Inc: other filings, last Dec 19, 2025

Get free alerts when Eric C Hsu files a new trade →